Neil Kumar - Dec 24, 2024 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
Chief Executive Officer, Director
Signature
/s/ Brian C. Stephenson, Attorney-in-Fact
Stock symbol
BBIO
Transactions as of
Dec 24, 2024
Transactions value $
$0
Form type
4
Date filed
12/27/2024, 07:05 PM
Previous filing
Dec 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Gift $0 -4.69M -95.68% $0.00 212K Dec 24, 2024 Direct
transaction BBIO Common Stock Gift $0 +4.69M +462.69% $0.00 5.7M Dec 24, 2024 By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. F1
holding BBIO Common Stock 996K Dec 24, 2024 By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.